NCT01023178View on ClinicalTrials.gov

Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Ovarian Failure, Premature
Interventions
DRUG

17beta Estradiol

Oral pill given daily at increasing doses every 6 months for 18 months.

DRUG

Conjugated estrogens

Oral pill, started at a low dose taken daily, dose increased every 6 months for 18 months

DRUG

17Beta Estradiol - transdermal

Transdermal estrogen patch, started at low dose with increasing doses eery 6 months for 18 months

DRUG

Progesterone, micronized

Given starting at 18 months

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01023178 - Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure | Biotech Hunter | Biotech Hunter